Triple Leveraged Biotech Fund Sees Massive Outflows As Biotech Cools (LABU)

With Biotech stocks running into a speed-bump in the past couple sessions including today, we have seen some liquidations in the levered long LABU (Direxion Daily S&P Biotech Bull 3X, Expense Ratio 1.09%).
NYSE:LABU September 6, 2017 12:20pm

Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

From Our Partners

5 WINNING Stock Chart Patterns

Most Popular



Explore More from ETFDailyNews.com

Free Investment Newsletter

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories